Caroline E. Fife, M.D., Latisha Smith, M.D., Jaime Aristizabal, M.D., Karen Parker, R.N.
Dr. Fife has done research supported by NASA, Organogenesis, Inc, Bedfont Scientific Ltd., National Headache Foundation, BristolMyersSquibb, R.W. Johnson Pharmaceuticals and Ciba. Dr. Smith has done research supported by Parke Davis/Warner Lambert, Chrysalis, Inc. and Organogenesis, Inc, and has given lectures supported by Ortho-McNeil. Dr. Aristizabal and Ms. Parker reports no commercial conflict of interest.
This activity is made possible by an unrestricted educational grant from the Novartis Foundation for Gerontology.
Estimated course time: 1 hour(s).
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®, you should be able to:
Identify the clinical indications for using semi-synthetic human skin in a non-healing wound
Describe the proposed mechanism of action of semi-synthetic human skin in effecting wound closure
Discuss the basic issues relating to chronic wound management.
